A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

Clinical trial NCT06496971 · RECRUITING

Trial details

NCT number: NCT06496971
Sponsor: NaviFUS Corporation
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Glioblastoma Multiforme Glioblastoma Glioblastoma Multiforme, Adult Glioma Brain Tumor Brain Tumor, Recurrent Neoplasms Neoplasms, Nerve Tissue

Start date: 2024-11-08
Primary completion: 2026-12-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.